Project Grant HT94252310174

Award Date 5/1/23
Completion Date 4/30/27
Dollars Obligated $2.5M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tucson, AZ 85721, USA
Similar Awards
This $300,378 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at the University of Arizona to identify a male-specific mechanism of nociceptor sensitization that promotes migraine in active-duty service members and veterans. The research aims to develop new treatments, diagnostic tools, and clinical practice guidelines to improve the health and care of military personnel and their families. As an...
The University of Arizona, through its Arizona Board of Regents, was awarded a $687,884 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING PROLACTIN FOR PREVENTION OF FEMALE-SELECTIVE NOCICEPTOR SENSITIZATION FOR TREATMENT OF FEMALE-PREDOMINANT PAIN SYNDROMES". This 4-year research project, with a start date of September 1, 2023, aims to transform healthcare for Service Members and the...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program is funding research at the University of Arizona to target drug resistance in the bone microenvironment using a novel PIM-PROTAC approach. The $1,791,407.00 award has a performance period from March 1, 2025 to February 29, 2028. This research effort aims to transform healthcare for military service members and the public by exploring...
This $306,971 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research into the "Neurovascular Mechanisms of Depression and Implications in Cardiovascular Health" at the University of Arizona. The 2-year grant, which commenced on April 1, 2024, funds basic and applied research activities by the University to investigate the relationships between neurological, vascular, and psychological...
This federal Project Grant award, totaling $3,069,903.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research at the University of Arizona to investigate the effectiveness of transcranial magnetic stimulation of the default mode network to improve sleep. The award has a performance period from September 1, 2024 to August 31, 2027. As a recognized 1862 land grant institution and Hispanic Serving...
The University of Arizona received a $2,997,638 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2022 through September 2025 to regulate mood and suicidal ideation through morning light exposure treatment for individuals with traumatic brain injury. The Military Medical Research and Development program supports basic, applied, and advanced...
The University of Arizona, doing business as the Arizona Board of Regents, received a $537,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2023, will fund research to decrease lung tumor progression through the transcriptional reprogramming of tumor-associated endothelial cells. The project will be conducted at the University of Arizona's facilities in Tucson, Arizona, and is scheduled...
The University of Arizona, through the Arizona Board of Regents, was awarded a $3,004,651 Project Grant from the Defense Health Agency to develop a treatment for neuropsychological and memory impairments following moderate to severe traumatic brain injury. This grant, awarded under the Military Medical Research and Development (CFDA 12.420) program, funds a research project aimed at advancing scientific understanding and improving patient care for service members and veterans affected by...
The University of Arizona will receive $724,825 through September 2026 under a Project Grant from the Defense Health Agency. The grant supports the development of osseosurface electronics to monitor rehabilitation and accelerate return to duty following surgical treatment of long bone fractures. This award furthers the goals of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative medical research solutions...
This $1,195,956 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and translation of a virtual reality-based military operational neuropsychological assessment tool. The funding will enable the University of Arizona, as the prime awardee, to create and validate a model for this innovative virtual reality assessment system. The anticipated completion date for this 3-year effort is September 29,...

The University of Arizona was awarded a $2.456 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to identify the role of the rostral ventromedial medulla in mediating postoperative thermal and mechanical hypersensitivity reduction after green light exposure. As the prime grantee, the University of Arizona will conduct the scientific research at its facilities in Tucson, Arizona to advance understanding of medical solutions for pain management related to surgical recovery and explore potential applications for light therapy techniques. No subawards or additional context were provided.

Generated 2/6/24, 6:09 AM